97 related articles for article (PubMed ID: 7607414)
41. Relation of Serum Lipoprotein(a) Levels to Lipoprotein and Apolipoprotein Profiles and Atherosclerotic Diseases in Japanese Patients with Heterozygous Familial Hypercholesterolemia: Familial Hypercholesterolemia Expert Forum (FAME) Study.
Naito R; Daida H; Masuda D; Harada-Shiba M; Arai H; Bujo H; Ishibashi S; Koga N; Oikawa S; Yamashita S
J Atheroscler Thromb; 2022 Aug; 29(8):1188-1200. PubMed ID: 34456199
[TBL] [Abstract][Full Text] [Related]
42. Lp(a) levels in Greek patients with heterozygous familial hypercholesterolemia.
Elisaf M; Bairaktari H; Siamopoulos KC
Int J Cardiol; 1996 Mar; 53(3):314-6. PubMed ID: 8793588
[TBL] [Abstract][Full Text] [Related]
43. Lipoprotein(a) Genotype Influences the Clinical Diagnosis of Familial Hypercholesterolemia.
Olmastroni E; Gazzotti M; Averna M; Arca M; Tarugi P; Calandra S; Bertolini S; Catapano AL; Casula M;
J Am Heart Assoc; 2023 May; 12(10):e029223. PubMed ID: 37183858
[TBL] [Abstract][Full Text] [Related]
44. Rhesus monkey model of familial hypercholesterolemia: relation between plasma Lp[a] levels, apo[a] isoforms, and LDL-receptor function.
Neven L; Khalil A; Pfaffinger D; Fless GM; Jackson E; Scanu AM
J Lipid Res; 1990 Apr; 31(4):633-43. PubMed ID: 2141055
[TBL] [Abstract][Full Text] [Related]
45. Ascertainment Bias in the Association Between Elevated Lipoprotein(a) and Familial Hypercholesterolemia.
Trinder M; DeCastro ML; Azizi H; Cermakova L; Jackson LM; Frohlich J; Mancini GBJ; Francis GA; Brunham LR
J Am Coll Cardiol; 2020 Jun; 75(21):2682-2693. PubMed ID: 32466883
[TBL] [Abstract][Full Text] [Related]
46. Molecular analysis of apo(a) fragmentation in polygenic hypercholesterolemia: characterization of a new plasma fragment pattern.
Gonbert S; Saint-Jore B; Giral P; Doucet C; Chapman J; Thillet J
Arterioscler Thromb Vasc Biol; 2001 Aug; 21(8):1353-8. PubMed ID: 11498465
[TBL] [Abstract][Full Text] [Related]
47. Analysis of lipid metabolism and its impact on the risk of ischemic heart disease in patients with definite familial hypercholesterolemia.
Korneva V; Kuznetsova T; Julius U
Atheroscler Suppl; 2017 Nov; 30():56-62. PubMed ID: 29096862
[TBL] [Abstract][Full Text] [Related]
48. Elevated plasma lipoprotein(a) associated with abnormal stress thallium scans in children with familial hypercholesterolemia.
Hegele RA; Connelly PW; Cullen-Dean G; Rose V
Am J Cardiol; 1993 Aug; 72(5):402-6. PubMed ID: 8352182
[TBL] [Abstract][Full Text] [Related]
49. Serum lipoprotein(a) levels differ in different phenotypes of primary hyperlipoproteinemia.
Hiraga T; Okubo M; Kobayashi T; Nakanishi K; Sugimoto T; Murase T
Metabolism; 1993 Oct; 42(10):1327-30. PubMed ID: 8412746
[TBL] [Abstract][Full Text] [Related]
50. Defects in the low density lipoprotein receptor gene affect lipoprotein (a) levels: multiplicative interaction of two gene loci associated with premature atherosclerosis.
Utermann G; Hoppichler F; Dieplinger H; Seed M; Thompson G; Boerwinkle E
Proc Natl Acad Sci U S A; 1989 Jun; 86(11):4171-4. PubMed ID: 2524837
[TBL] [Abstract][Full Text] [Related]
51. Lipoprotein (a) metabolism estimated by nonsteady-state kinetics.
Parhofer KG; Demant T; Ritter MM; Geiss HC; Donner M; Schwandt P
Lipids; 1999 Apr; 34(4):325-35. PubMed ID: 10443965
[TBL] [Abstract][Full Text] [Related]
52. The Apo(a) gene is the major determinant of variation in plasma Lp(a) levels in African Americans.
Mooser V; Scheer D; Marcovina SM; Wang J; Guerra R; Cohen J; Hobbs HH
Am J Hum Genet; 1997 Aug; 61(2):402-17. PubMed ID: 9311746
[TBL] [Abstract][Full Text] [Related]
53. Lipoprotein(a) concentrations and phenotypes in controls and patients with hypercholesterolemia or hypertriglyceridemia.
Ritter MM; Geiss HC; Richter WO; Schwandt P
Metabolism; 1994 May; 43(5):572-8. PubMed ID: 8177045
[TBL] [Abstract][Full Text] [Related]
54. Plasma lipoprotein (a) levels in children with minimal lesion nephrotic syndrome.
Nakahara C; Kobayashi K; Hamaguchi H; Kanemoto K; Kashiwagi R; Matsui A
Pediatr Nephrol; 1999 Oct; 13(8):657-61. PubMed ID: 10502122
[TBL] [Abstract][Full Text] [Related]
55. Genetic determination of plasma apolipoprotein AI in a population-based sample.
Moll PP; Michels VV; Weidman WH; Kottke BA
Am J Hum Genet; 1989 Jan; 44(1):124-39. PubMed ID: 2491774
[TBL] [Abstract][Full Text] [Related]
56. Hypercholesterolemia in five Israeli Christian-Arab kindreds is caused by the "Lebanese" allele at the low density lipoprotein receptor gene locus and by an additional independent major factor.
Oppenheim A; Friedlander Y; Dann EJ; Berkman N; Schwartz SP; Leitersdorf E
Hum Genet; 1991 Nov; 88(1):75-84. PubMed ID: 1959928
[TBL] [Abstract][Full Text] [Related]
57. The genetics of quantitative plasma Lp(a): analysis of a large pedigree.
Hasstedt SJ; Wilson DE; Edwards CQ; Cannon WN; Carmelli D; Williams RR
Am J Med Genet; 1983 Oct; 16(2):179-88. PubMed ID: 6228142
[TBL] [Abstract][Full Text] [Related]
58. Lipoprotein(a) concentration is associated with plasma arachidonic acid in subjects with familial hypercholesterolaemia.
Narverud I; Bogsrud MP; Øyri LKL; Ulven SM; Retterstøl K; Ueland T; Mulder M; Roeters van Lennep J; Halvorsen B; Aukrust P; Veierød MB; Holven KB
Br J Nutr; 2019 Oct; 122(7):790-799. PubMed ID: 31262370
[TBL] [Abstract][Full Text] [Related]
59. SLC22A3 is associated with lipoprotein (a) concentration and cardiovascular disease in familial hypercholesterolemia.
Paquette M; Bernard S; Baass A
Clin Biochem; 2019 Apr; 66():44-48. PubMed ID: 30772277
[TBL] [Abstract][Full Text] [Related]
60. Reduction of Lp(a) by different methods of plasma exchange.
Schenck I; Keller C; Hailer S; Wolfram G; Zöllner N
Klin Wochenschr; 1988 Dec; 66(24):1197-201. PubMed ID: 2976858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
